South African men are much more likely to die from TB than women—here's why
Around the world, men are more likely to get TB and to die from it than women.
Sep 29, 2023
0
0
Around the world, men are more likely to get TB and to die from it than women.
Sep 29, 2023
0
0
Tuberculosis is old—ancient even. The infectious bacterial disease that plagued Old Testament Israelites and took down pharaohs was eventually stunted by vaccinations, antibiotics, and public health measures like isolation, ...
Sep 27, 2023
0
42
The first global review of the effectiveness of current strategies to fight tuberculosis—the leading infectious cause of death globally—has found preventive therapy is the most effective intervention strategy.
Sep 27, 2023
0
35
New research from the University of Missouri School of Medicine suggests there may be another way to treat cigarette cravings. Researchers found that theta-burst transcranial magnetic stimulation (TBS)—strong, rapidly fluctuating ...
Sep 20, 2023
0
37
A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George's, University of London. Results have been ...
Aug 29, 2023
0
17
For centuries, we have known that tuberculosis is a social disease. It thrives on poverty and social factors such as malnutrition, poor housing, overcrowding, unsafe work environments and stigma.
Aug 28, 2023
0
9
Mycobacterium tuberculosis (Mtb) is the pathogen that causes tuberculosis (TB), the world's deadliest infectious disease. Mtb is so successful and harmful because it can adapt to different conditions inside our bodies, allowing ...
Aug 8, 2023
0
25
Administering preventive tuberculosis (TB) treatment to contacts of infected people could significantly cut deaths, and save money, researchers say.
Aug 8, 2023
0
1
Tuberculosis (TB) disproportionately affects vulnerable populations including those with limited economic resources, HIV patients, those whose diet is deficient in nutrients and others. Resistant TB (MDR TB) does not respond ...
Jul 31, 2023
0
12
The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment.
Jul 5, 2023
0
2